BICO Group

40,57SEK -5,19 %
1 investor følger denne virksomhed

BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.

Omsætning
2,24 mia.
EBIT %
-44,51 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BICO
Daglig lav / høj pris
40,1 / 42,59 SEK
Markedsværdi
2,8 mia. SEK
Aktieomsætning
13,47 mio. SEK
Volumen
329 t
BICO appoints COO

Selskabsmeddelelse05.01.2023
BICO Group Appoints New CFO

Selskabsmeddelelse02.01.2023